Red Network Moment December 14 news (correspondent Liu Min Xiao Hongmei Shen Xinggang) When it comes to tumors, many people first think of solid tumors, such as liver cancer, stomach cancer, lung cancer, breast cancer, etc., and for blood tumors, everyone's cognition is relatively limited. In fact, in daily life, blood tumors are not rare, such as the familiar leukemia, lymphoma, multiple myeloma, etc. belong to the category of blood tumors.
In the First Affiliated Hospital of Shaoyang University, there is such a team, they are committed to holding up the dawn of life for tumor patients, and have a strong advantage in the precise treatment, minimally invasive diagnosis and treatment of malignant entities and hematological system tumors, and the whole process management; they insist on taking the patient as the center and taking the lead in promoting the construction of "vomit-free wards" in Shaoyang area, so that chemotherapy will no longer become a nightmare for patients. This team is the hematology and oncology medical team.
Precision diagnosis and treatment makes "tumors" no longer terrible
A few years ago, Ms. Hu was diagnosed with myelodysplastic syndrome when she went to a provincial hospital for examination due to severe anemia, fatigue and pallor. Myelodysplastic syndrome is a malignant tumor of the blood system, and at that time, the doctor told Ms. Hu that her life was not more than three months. With the last glimmer of hope, Ms. Hu, accompanied by her family, went to the First Affiliated Hospital of Shaoyang University and found Chen Yingzhao, director of the Department of Hematology and Oncology. After Chen Yingzhao learned more about Ms. Hu's condition, she developed a precise treatment plan for her, helping Ms. Hu restore her autonomous hematopoietic function through repeated blood transfusions and comprehensive treatment. At the same time, through psychological counseling and attentive nursing services, She has won the recognition of Ms. Hu, and so far Ms. Hu has fully recovered and no longer needs blood transfusion treatment within two years.
In 2016, a lung cancer patient, Mr. Chen, suffered from cerebral metastasis and hemiplegia on one side of his body, and was diagnosed by other hospitals to live for less than three months. The family was extremely anxious, and after many inquiries, they came to the First Affiliated Hospital of Shaoyang University. A multidisciplinary team of experts consults patients, and later through chemotherapy and various comprehensive treatments, now, 4 years later, patients are still living healthily.
"People like Ms. Hu and Mr. Chen who create miracles of life often happen in our clinics." Chen Yingzhao said that in the past, people talked about cancer discoloration, one is because malignant tumors are indeed the "number one killer" who threatens the lives of the people, with high mortality and great pain; on the other hand, because many people lack a comprehensive and objective understanding of malignant tumors and blindly panic. Nowadays, with the continuous development and improvement of the level of medical technology, the treatment methods for malignant tumors are also constantly updated and improved. Conventional treatment methods include surgery, chemotherapy, radiotherapy, but also a combination of mature conventional therapy and high-end technologies, such as immunotherapy and molecular targeted therapy. "If properly controlled, the tumor is a chronic disease, standardized treatment, control of complications, life can continue to move forward." Chen Yingzhao introduced that the key to tumor treatment is "standardization", which requires doctors to give one-on-one, customized and precise treatment plans according to the patient's situation. At the same time, multidisciplinary coordination is also needed, especially in malignant solid tumors, and comprehensive postoperative treatment and full management are extremely important, which can effectively prolong the survival of patients.
The "vomit-free ward" makes chemotherapy no longer a nightmare
When Mr. Zhu, a 55-year-old stomach cancer patient, underwent postoperative adjuvant chemotherapy in a hospital, he could not bear the pain caused by chemotherapy and chose to give up and return to his hometown in Shaoyang. In the Department of Hematology and Oncology of the First Affiliated Hospital of Shaoyang University, through the construction of the hospital's "no vomiting ward", the whole process of seamless course management has begun, and the vomiting of tumor patients has been reduced, the trust in medical staff has been higher, and the treatment effect has become better and better.
As we all know, chemotherapy is one of the important treatments for malignant tumors. Especially in the treatment of hematological tumors, tumor cells are mainly concentrated in hematopoietic organs such as peripheral blood circulation, liver, spleen, lymph nodes, etc., and chemical drugs enter the human body through veins, and they mainly exist in these systems, so the contact time between tumors and drugs is relatively long, and the killing effect is better. However, the vomiting and nausea caused by the side effects of chemotherapy have made many tumor patients daunted and even abandoned treatment.
How to improve the compliance of cancer patients with chemotherapy treatment? How to make patients no longer afraid of "chemotherapy"? This is the question that Chen Yingzhao has been thinking about.
In August 2020, in order to better alleviate the pain caused by radiotherapy and chemotherapy to patients and improve the medical experience, the department took the lead in launching the construction of "no vomiting ward" in Shaoyang area, and implemented the "no vomiting ward" project through the internationally accepted "triple" and "quadruple" standards. "There are fewer vomiting patients, and the patient's fear psychology is also alleviated a lot." Chen Yingzhao introduced that in the oncology department, there is a term called five-year survival rate, which is usually used to evaluate the treatment effect of patients. The standardized management of the course of the disease is directly related to the five-year survival rate of patients and is an important part of cancer prevention and control. Therefore, the construction of a "no vomiting ward" so that the nausea and vomiting caused by chemotherapy no longer become a nightmare for patients, can effectively improve the patient's compliance with chemotherapy treatment.
The department also specially produced a vomiting self-examination form, on the one hand, to accelerate the training of oncologists and nurses, on the other hand, to strengthen the health education of patients, to help cancer treatment, has won the praise of patients and their families.
"Excellence" wholeheartedly protects the health of patients
In March this year, a female patient due to dizziness, nausea, urine color deepening, admitted to the hematology clinic, after examination found that the patient has thrombocytopenia, microangiopathic hemolytic anemia, nervous system abnormalities, kidney function damage, experienced Chen Yingzhao suspected that the patient may have thrombotic thrombocytopenic purpura (TTP), this disease is extremely rare, the condition is dangerous, the case fatality rate is extremely high. Chen Yingzhao quickly turned to the MDT team in the hospital for help, immediately launched a multidisciplinary expert consultation, and transferred the patient to the ICU for further monitoring and treatment. Finally, through a combination of 3,000 ml per day, 20 consecutive plasma exchanges, and a series of immunomodulatory, anti-infective, corrective anemia, nutritional support, and other comprehensive treatments, the patient was pulled back from the brink of death.
Over the years, under the leadership of Chen Yingzhao, the department has developed into a hematological tumor treatment center integrating three sub-disciplines of chest and head and neck malignancy, gastrointestinal malignancy, leukemia and lymphoma, and has built a comprehensive treatment system of radiation therapy, chemotherapy, interventional therapy, targeted therapy, gene monitoring, immunotherapy and other means of malignant tumors, which is a key specialty in Shaoyang City.
The department took the lead in carrying out percutaneous lung puncture, pancreatic malignant tumor endoscopic interventional puncture, pleural laparoscopic biopsy, bone marrow biopsy in Shaoyang area; in 2015, targeted treatment of solid malignant tumors, lymphoma, leukemia, and carried out bisphosphate treatment and standardized pain analgesic treatment for bone metastatic carcinoma; in 2017, the department carried out appropriate intensity-modulated radiotherapy for malignant solid tumors, and in 2018, it carried out immunotherapy for malignant tumors.
The department has a team of experts with rich clinical experience, solid scientific research foundation, innovative vitality and reasonable talent echelon. In terms of medical services, medical quality, teaching and scientific research, they are at the forefront of Shaoyang area and have become a solid reliance for cancer patients. At the same time, the department also actively promotes hierarchical diagnosis and treatment, and has established medical associations with Hunan Provincial Cancer Hospital and a number of county (district) grass-roots hospitals to provide regular guidance and training for grass-roots hospitals. Actively participate in the publicity of cancer prevention and treatment, have popularized the knowledge of prevention and treatment in many communities and universities for the elderly, and obtained good social benefits; every year, by participating in or organizing large-scale tumor academic conferences, we continuously improve the academic development level of tumor disciplines in Shaoyang area, and actively and effectively defend the health of tumor patients in Shaoyang area.
In the face of increasing incidence of tumor diseases, Chen Yingzhao reminded the general public that we must pay attention to anti-cancer screening, actively prevent it, and reduce the incidence of hematologic malignant tumors. In particular, people with high risk of cancer in relatives must be screened in time; people who are ≥ 40 years old need to do cancer prevention screening once a year; in addition, people who are often exposed to radioactive substances, fuels, paints, decoration materials and people who are in sub-health for a long time must do a good job of cancer screening to prevent problems before they occur. She said that tumors are preventable and controllable, and their onset requires a long-term process, before it evolves into a tumor, or in the early stage of tumors, timely anti-cancer screening is carried out, so that early detection, early diagnosis, and early treatment can improve the quality of life.